Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental cyclophosphamide poisoning |
Causative agent (attribute) |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional cyclophosphamide poisoning |
Causative agent (attribute) |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par le cyclophosphamide d'intention indéterminée |
Causative agent (attribute) |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide adverse reaction |
Causative agent (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide allergy |
Causative agent (attribute) |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide overdose |
Causative agent (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental cyclophosphamide overdose |
Causative agent (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional cyclophosphamide overdose |
Causative agent (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de cyclophosphamide d'intention indéterminée |
Causative agent (attribute) |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 20mg/mL infusion solution 200mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 2g/100mL infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 1g/50mL infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 100mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 200mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 500mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 1g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 2g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 100mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 1000mg/vial (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cyclophosphamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning caused by cyclophosphamide (disorder) |
Causative agent (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 200mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 1g/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 500mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 1 gram/1 vial powder for conventional release solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental cyclophosphamide poisoning |
Causative agent (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional cyclophosphamide poisoning |
Causative agent (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide allergy |
Causative agent (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide therapy (procedure) |
Direct substance |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
R-CHOP chemotherapy regimen |
Direct substance |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
8 |
Cyclophosphamide monohydrate (substance) |
Is a |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide monohydrate (substance) |
Is modification of (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclophosphamide 25 mg oral tablet |
Has precise active ingredient |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 50 mg oral tablet |
Has precise active ingredient |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection |
Has basis of strength substance (attribute) |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 1 gram/1 vial powder for conventional release solution for injection |
Has basis of strength substance (attribute) |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 200 milligram/1 vial powder for conventional release solution for injection |
Has basis of strength substance (attribute) |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 500 milligram/1 vial powder for conventional release solution for injection |
Has basis of strength substance (attribute) |
False |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cyclophosphamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cyclophosphamide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cyclophosphamide in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy |
Direct substance |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
5 |
Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclophosphamide 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 200 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 200 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 500 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 500 mg powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 1 g powder for solution for injection vial |
Has precise active ingredient |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide 1 g powder for solution for injection vial |
Has basis of strength substance (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclophosphamide anhydrous (substance) |
Is modification of (attribute) |
True |
Cyclophosphamide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|